NCT03087851View on ClinicalTrials.gov

Treatment With Zoledronic Acid Subsequent to Denosumab in Osteoporosis

PHASE4CompletedINTERVENTIONAL

Enrollment

61

Participants

Timeline

Start Date

March 13, 2017

Primary Completion Date

August 1, 2020

Study Completion Date

August 1, 2020

Conditions

Osteoporosis

Interventions

DRUG

Zoledronic Acid

Intravenous infusion of 5 mg zoledronic acid

Trial Locations (1)

8000

Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Denmark, Aarhus

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

University of Aarhus

OTHER

collaborator

Amgen

INDUSTRY

lead

Aarhus University Hospital

OTHER